Status: Recruiting
Zephyr Valve Japan Post-Marketing Surveillance
This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.
Participants needed: 140
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Pulmonx CorporationUpdated: Sep 17, 2026Locations: 17
Eligibility criteria
Recent respiratory rehabilitation completed within the last 6 months [+10]